The 45-Day First-Form Sprint

The decision before the commitment.

45

A bounded validation engagement for one health idea approaching a consequential funding, partnership, pilot, implementation, or launch decision.

45 daysFrom promising idea to decision-grade operating form.
Buyer-ownedThe pathway, architecture, risk map, plan, and brief belong to you.
ConfidentialThe work is held in confidence unless publication is jointly agreed.

From proposition to decision

01IdeaWhat is being proposed?
02First personWho must it help?
03PathwayHow must it work?
04EvidenceWhat must be observed?
05DecisionWhat should happen next?

What the engagement resolves

Is the model ready for its next exposure?

FHIL examines the proposition, intended user, available evidence, operating environment, and institutional constraints.

Where analysis alone is insufficient, we design the smallest operating version required to test the model. The sprint does not build the full-scale system. It builds enough of the operating form to determine what the next commitment should be.

FundTestRedesignLaunchScaleStop

What you receive

Six outputs tied to one decision.

01

First-person definition

Who the model must help first, the problem it must resolve, and the observable change that matters.

02

Operating pathway

The sequence from first contact to useful outcome, including roles, handoffs, trust points, and escalation paths.

03

Prototype or pilot architecture

The smallest observable version capable of testing the model’s most consequential assumptions.

04

Risk map

The clinical, operational, institutional, behavioral, and implementation risks most likely to break the model.

05

Validation plan

The evidence that must be generated before additional capital or institutional commitment is justified.

06

Decision brief

What is ready, what remains uncertain, what must be tested, and what should happen next.

How it works

Frame. Map. Test. Decide.

  1. 01

    Frame the decision

    Clarify the pending commitment, the first person, the intended outcome, and the uncertainties that matter most.

  2. 02

    Map the operating reality

    Make roles, actions, handoffs, trust, escalation, institutional constraints, and failure points explicit.

  3. 03

    Build what must be observed

    Create the minimum pathway, prototype, or pilot architecture needed to test the highest-risk assumptions.

  4. 04

    Produce the next decision

    State what is ready, what is not, the evidence still required, and the most defensible next commitment.

Strong fit

The sprint is useful when learning later will cost more.

  • An idea is promising but operationally abstract.
  • A funding, sponsorship, partnership, or launch decision is approaching.
  • The pathway and handoffs are assumed rather than observed.
  • A pilot is producing activity but not decision-grade evidence.
  • An independent basis to proceed, redesign, or stop is needed.

What the buyer brings

  • Access to the proposition and available evidence.
  • A named decision owner.
  • Relevant subject-matter and operating stakeholders.
  • Timely access to the context in which the model must work.

What remains outside the sprint

  • Full-scale product or program implementation.
  • A promise of clinical, commercial, or population outcomes.
  • Substitution for legal, regulatory, or clinical authority.
  • Capital raising or a predetermined recommendation to proceed.

Begin a conversation

Bring the idea before the exposure grows.

Share the health idea, who it must help first, the decision ahead, and why it matters now.

victorladele@fhilabs.com

External perspective

Ask AI
about me.

Choose a provider. A new tab will open with the question ready for you to review and send.

Tell me about Victor Ladele based on physician, public health expert, and global health innovator in health and AI, which is my domain. Summarize who they are, what they do, and how to get in touch.

Third-party AI answers can vary and may be incomplete. Verify consequential details directly with FHIL.